z-logo
open-access-imgOpen Access
A social significance of the pharmacogenetic testing in Ukraine on the example of the CYP2B6 gene participating in the nicotine metabolism
Author(s) -
M. M. Kobets,
О. В. Філіпцова,
Yu. M. Kobets
Publication year - 2018
Publication title -
news of pharmacy
Language(s) - English
Resource type - Journals
eISSN - 2415-8844
pISSN - 1562-7241
DOI - 10.24959/nphj.18.2204
Subject(s) - genotyping , pharmacogenetics , cyp2b6 , nicotine , medicine , bupropion , pharmacology , addiction , population , nicotine replacement therapy , smoking cessation , cyp2a6 , genetic testing , oncology , psychiatry , genotype , genetics , gene , environmental health , biology , cytochrome p450 , cyp1a2 , pathology , metabolism , cyp3a4

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom